FS Development Holdings II, LLC - 23 Dec 2021 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role
10%+ Owner
Signature
/s/ Dennis Ryan, on behalf of FS Development Holdings II, LLC
Issuer symbol
N/A
Transactions as of
23 Dec 2021
Net transactions value
$0
Form type
4
Filing time
28 Dec 2021, 15:00:20 UTC
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRDS Common Stock Conversion of derivative security $0 +4,873,750 $0.000000 4,873,750 23 Dec 2021 Direct F1
holding PRDS Common Stock 602,500 23 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Common Stock Conversion of derivative security $0 -4,873,750 -100% $0.000000* 0 23 Dec 2021 Common Stock 4,873,750 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

FS Development Holdings II, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer.